Performance of the Research. 2.1. In consideration of the sums to be paid by the Company to Yeda pursuant to clause 3 below and, subject to the execution of such payments, Yeda undertakes, subject to clause 2.2 below, to procure the performance of the Research at the Institute under the supervision of the Scientist during the 3 (three) year period commencing on April 9, 2003 ("THE RESEARCH PERIOD"). By written agreement of the parties, the Research Period may be extended by such period and upon such terms and conditions as the parties shall so agree.
2.2. If the Scientist shall cease to be available for the supervision of the performance of the Research, such cessation shall not constitute a breach of this Agreement by Yeda. In the event that the Scientist shall cease to be available as aforesaid, Yeda shall use its reasonable efforts to find from amongst the scientists of the Institute a replacement scientist acceptable to the Company (such acceptance to be in writing, and not to be unreasonably withheld) but no undertaking to find such a replacement is given by Yeda. If no such acceptable replacement scientist can be found within 30 (thirty) days of the Scientist becoming unavailable as aforesaid, then the Company shall be entitled, by written notice to Yeda, to terminate the Research Period, in which event the Research Period and the performance of Research hereunder shall cease at the end of a further period of 15 (fifteen) days from the date of receipt by Yeda of such written notice. In the event of such termination, Yeda shall be released from any obligation to procure the performance of the Research during the period after such termination. The Company shall be released from any obligation to finance the Research in respect of the period commencing at the end of 45 (forty five) days after the unavailability of the Scientist, but without affecting the Licence and all the other terms and conditions of this Agreement which shall remain in full force and effect (save for those relating to the performance and financing of the Research).
2.3. For the avoidance of doubt, it is agreed that nothing in this Agreement shall constitute a representation or warranty by Yeda, express or implied, that any results (including any milestones specified in the Research Program) will be achieved by the Research or that the Licensed Information or any part thereof or any results achieved by the Research are or will be commercially exploitable or of any other value and Yeda furthermore makes no warran...
Performance of the Research. SIGNAL agrees to use its commercially reasonable and diligent efforts consistent with prevailing practices within the pharmaceutical and biotechnology industries to perform, and as necessary to cause its agents, consultants and/or academic collaborators to perform, the Research. SIGNAL shall accord the Research at least as high a priority as it accords its other active research programs for which it receives comparable funding. SIGNAL shall cooperate with ARES in the performance of the Research as required by the relevant Protocols.
Performance of the Research. 1. Engagement COLLABORATOR agrees to engage the services of UNIVERSITY as an independent contractor to perform the Research. The Research will be under the supervision of Dr.
Performance of the Research. The Parties shall perform the Research in accordance with (i) the terms of this Agreement; (ii) relevant professional standards; and (iii) all applicable local, state, and federal laws, rules, regulations, and official guidance, including, but not limited to, applicable provisions of the Health Insurance Portability and Accountability Act of 1996 as amended by the Health Information Technology For Economic and Clinical Health Act (“HITECH”) (collectively “HIPAA”) and other applicable laws and regulations relating to the security or confidentiality of Protected Health Information (“PHI”), the Centers for Disease Control guidelines, the Occupational Safety and Health Act of 1970 and its implementing regulations, all laws and regulations applicable to the Company Materials, the Federal Food, Drug and Cosmetic Act, and all applicable implementing regulations issued thereunder (collectively. “Applicable Law”).
Performance of the Research. (a) Promptly following the Effective Date, Intec Pharma shall perform the activities set forth in PART A of the Research Plan, which include activities related to initial bench-scale research and development of Collaboration Products. Promptly following completion of the activities set forth in PART A of the Research Plan, Intec Pharma shall deliver to Biogen the deliverables specified in PART A of the Research Plan (the “PART A Deliverables”), which PART A Deliverables shall comply with the requirements and specifications set forth in the Research Plan. Within ninety (90) days after receipt of the PART A Deliverables, Biogen shall notify Intec Pharma in writing if it desires to proceed with PART B of the Research Plan (a “PART B Election Notice”). If Biogen does not deliver a PART B Election Notice to Intec Pharma within ninety (90) days after receipt of the PART A Deliverables, then this Agreement shall automatically terminate on the end of such ninety (90) day period, and Biogen shall reimburse Intec Pharma’s out-of-pocket costs incurred in the performance of the Research Plan in accordance with Section 8.3.3 (Termination by Biogen during the Research Period), provided that, if Biogen notifies Intec Pharma within such ninety (90) day period of its decision not to deliver a PART B Election Notice, then Biogen shall have no obligation to reimburse Intec Pharma for any out-of-pocket costs incurred by Intec Pharma after the date of such notification. NOTE: PORTIONS OF THIS EXHIBIT ARE THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST BY THE REGISTRANT TO THE SECURITIES AND EXCHANGE COMMISSION (“COMMISSION”). SUCH PORTIONS HAVE BEEN REDACTED AND FILED SEPARATELY WITH THE COMMISSION AND ARE MARKED WITH A “[***]” IN PLACE OF THE REDACTED LANGUAGE.
(b) If Biogen delivers a PART B Election Notice to Intec Pharma within ninety (90) days after receipt of the PART A Deliverables, then Intec Pharma shall promptly commence and perform the activities set forth in PART B of the Research Plan, which includes activities related to the Pre-Commercialization Activities and Manufacture of GMP-compliant clinical batches of Collaboration Product (the “Phase 1 Clinical Trial Materials”). Promptly following completion of the activities set forth in PART B of the Research Plan, Intec Pharma shall deliver the Phase 1 Clinical Trial Materials to the clinical site(s) designated by Biogen and shall deliver any other deliverables specified in PART B of the Research Plan to Biogen or it...
Performance of the Research. The Company agrees to provide such resources (including all necessary personnel, equipment, tools, Company Provided Materials and supplies) and effort as is necessary to (A) perform the Research in the conduct of the Project in accordance with this Agreement, including the Project Description and (B) complete the Project (and each Phase thereof) within the time frame specified in the Project Description.
Performance of the Research. 2.1 The Research shall commence on the Effective Date and shall continue for a period of four (4) years.
2.2 The Research shall be carried out by the Student in the Department of Chemical Engineering at the University under the supervision of the Academie Supervisor. For the purposes of the Research, JM will be represented by the lndustrial Supervisor to whom all invoices and correspondence should be addressed. The University shall be entitled to change its nominee for the position of Academie Supervisor with XX's prior written consent, such consent not to be unreasonably withheld.
2.3 The Research shall be performed at the University, except that at the request of JM, the Student may spend up to ninety (90) days over the term of the Agreement (usually up to thirty (30) days per year) working on the Research at a JM Site at times which are convenient to JM.
2.4 The Student and aný University personnel who visit any JM Site shall comply with JM's site rules and regulations currently in farce governing the activities of those using JM premises, particularly those relating to JM's environment, health, safety and security standards and with any other instructions that may be given in this respect on JM's behalf.
2.5 The University shall use all reasonable endeavours to supply materials and equipment needed for those parts of the Research that are carried out at the University.
2.6 JM shall:
(i) use all reasonable endeavours to supply materials and equipment needed for those parts of the Research that are carried out at the JM Site; and
(ii) make available in confidence to the University and to the Student such Background lntellectual Property owned by XX as JM considers to be necessary for the efficient performance of the Research.
2.7 The University, JM and the Student shall take all reasonable steps to ensure satisfactory progress of the Research and its completion within four (4) years of the date of commencement of the Research.
2.8 The obligations of the University shall be limited to the making available of such Background lntellectual Property owned or controlled by the University as the University considers to be necessary for the efficient performance of the Research and the exercise of reasonable endeavours to ensure success of the Research. For the avoidance of doubt it is hereby declared that the University does not undertake that the Research will generate any particular information or guarantee that the Research will be successful in achieving an...
Performance of the Research. The Contractor will observe the principles laid down in the ALLEA code of conduct.
Performance of the Research. Isis agrees that (A) each Research FTE will perform the Research in accordance with this Agreement, including the Project Description and (B) no Research shall be performed except as expressly set forth in the Project Description or otherwise approved by the Steering Committee. During the Term (as defined in Section 17(a) of this Agreement), unless otherwise explicitly agreed to by the Steering Committee or expressly provided for in the Project Description, Isis will also provide such other resources (including all necessary administrative and support personnel, equipment, tools, Isis Provided Materials and supplies) and effort as is commercially reasonable to perform the Research in accordance with this Agreement, including the Project Description.
Performance of the Research. 4.1 The Contractor will observe the principles laid down in the ALLEA code of conduct.
4.2 The Contractor will notify informants to be involved in the research about the objective of the research and when and how the results are to be published, will guarantee, upon request, their anonymity and will use the information they provide exclusively for the stated objective.
4.3 In principle, the Services will be performed at the [Contracting Authority’s] [and/or the] [Contractor’s] offices.
